Hope for new developments in the reimbursement of oncological PET/CT in Germany

In Germany, health technology assessment (HTA) of new examination and treatment methods (“Neue Untersuchungs- und Behandlungsmethoden”, NUBs) like PET by the Joint Federal Committee (“Gemeinsamer Bundesausschuss”, G-BA) follows strict regulations from the Social Code Part V (“Sozialgesetzbuch Teil V”, SGB V). For the coverage of medical procedures by German statutory health insurances (“Gesetzliche Krankenversicherung”, GKV), a distinction is essentially made between outpatient and inpatient care sectors as well as a third sector of health care in Germany, the so-called outpatient specialist care (“Ambulante Spezialfachärztliche Versorgung”, ASV) according to § 116b SGB V.

Publication History

Article published online:
09 June 2021